Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

CT screening for lung cancer: Are we ready to implement in Europe?

Balata H, Evison M, Sharman A, Crosbie P, Booton R.

Lung Cancer. 2019 Aug;134:25-33. doi: 10.1016/j.lungcan.2019.05.028. Epub 2019 May 28. Review.

PMID:
31319989
2.

Corrigendum to "The impact of burial period on compact bone microstructure: histological analysis of matrix loss and cell integrity in human bones exhumed from tropical soil" [Forensic Sci. Int. 298C (2019) 384-392].

Astolphi RD, de Seixas Alves MT, Evison MP, Francisco RA, Guimarães MA, Iwamura ESM.

Forensic Sci Int. 2019 Jun 24;302:109863. doi: 10.1016/j.forsciint.2019.06.021. [Epub ahead of print] No abstract available.

PMID:
31247452
3.

Baseline predictors of negative and incomplete pleural cytology in patients with suspected pleural malignancy - Data supporting 'Direct to LAT' in selected groups.

Tsim S, Paterson S, Cartwright D, Fong CJ, Alexander L, Kelly C, Holme J, Evison M, Blyth KG.

Lung Cancer. 2019 Jul;133:123-129. doi: 10.1016/j.lungcan.2019.05.017. Epub 2019 May 16.

PMID:
31200818
4.

The impact of burial period on compact bone microstructure: Histological analysis of matrix loss and cell integrity in human bones exhumed from tropical soil.

Astolphi RD, de Seixas Alves MT, Evison MP, Francisco RA, Guimarães MA, Iwamura ESM.

Forensic Sci Int. 2019 May;298:384-392. doi: 10.1016/j.forsciint.2019.03.008. Epub 2019 Mar 14. Erratum in: Forensic Sci Int. 2019 Jun 24;302:109863.

PMID:
30928778
5.

Conformational Dynamics Underlies Different Functions of Human KDM7 Histone Demethylases.

Chaturvedi SS, Ramanan R, Waheed SO, Ainsley J, Evison M, Ames JM, Schofield CJ, Karabencheva-Christova TG, Christov CZ.

Chemistry. 2019 Apr 11;25(21):5422-5426. doi: 10.1002/chem.201900492. Epub 2019 Mar 26.

PMID:
30817054
6.

Conformational flexibility influences structure-function relationships in nucleic acid N-methyl demethylases.

Waheed SO, Ramanan R, Chaturvedi SS, Ainsley J, Evison M, Ames JM, Schofield CJ, Christov CZ, Karabencheva-Christova TG.

Org Biomol Chem. 2019 Feb 20;17(8):2223-2231. doi: 10.1039/c9ob00162j.

PMID:
30720838
7.

Predicting survival following surgical resection of lung cancer using clinical and pathological variables: The development and validation of the LNC-PATH score.

Balata H, Foden P, Edwards T, Chaturvedi A, Elshafi M, Tempowski A, Teng B, Whittemore P, Blyth KG, Kidd A, Ellames D, Flint LA, Robson J, Teh E, Jones R, Batchelor T, Crosbie P, Booton R, Evison M.

Lung Cancer. 2018 Nov;125:29-34. doi: 10.1016/j.lungcan.2018.08.026. Epub 2018 Aug 31.

PMID:
30429034
8.

Second round results from the Manchester 'Lung Health Check' community-based targeted lung cancer screening pilot.

Crosbie PA, Balata H, Evison M, Atack M, Bayliss-Brideaux V, Colligan D, Duerden R, Eaglesfield J, Edwards T, Elton P, Foster J, Greaves M, Hayler G, Higgins C, Howells J, Irion K, Karunaratne D, Kelly J, King Z, Lyons J, Manson S, Mellor S, Miller D, Myerscough A, Newton T, O'Leary M, Pearson R, Pickford J, Sawyer R, Screaton NJ, Sharman A, Simmons M, Smith E, Taylor B, Taylor S, Walsham A, Watts A, Whittaker J, Yarnell L, Threlfall A, Barber PV, Tonge J, Booton R.

Thorax. 2019 Jul;74(7):700-704. doi: 10.1136/thoraxjnl-2018-212547. Epub 2018 Nov 12.

9.

Targeted lung cancer screening selects individuals at high risk of cardiovascular disease.

Balata H, Blandin Knight S, Barber P, Colligan D, Crosbie EJ, Duerden R, Elton P, Evison M, Greaves M, Howells J, Irion K, Karunaratne D, Kirwan M, Macnab A, Mellor S, Miller C, Newton T, Novasio J, Sawyer R, Sharman A, Slevin K, Smith E, Taylor B, Taylor S, Tonge J, Walsham A, Waplington S, Whittaker J, Booton R, Crosbie PAJ.

Lung Cancer. 2018 Oct;124:148-153. doi: 10.1016/j.lungcan.2018.08.006. Epub 2018 Aug 8.

PMID:
30268454
10.

New drugs in thoracic oncology: needs and knowledge - an online ERS Lung Cancer Assembly survey.

Berghmans T, Evison M, Blum TG, Peled N, Cadranel J.

ERJ Open Res. 2018 Sep 3;4(3). pii: 00040-2018. doi: 10.1183/23120541.00040-2018. eCollection 2018 Jul.

11.

Forensic science policy and the question of governmental University research quality assessment.

Evison MP.

Forensic Sci Int. 2018 Sep;290:279-296. doi: 10.1016/j.forsciint.2018.07.028. Epub 2018 Aug 1.

PMID:
30121552
12.

Providing safe and effective pleural medicine services in the UK: an aspirational statement from UK pleural physicians.

Evison M, Blyth KG, Bhatnagar R, Corcoran J, Saba T, Duncan T, Hallifax R, Ahmed L, West A, Pepperell JCT, Roberts M, Sivasothy P, Psallidas I, Clive AO, Latham J, Stanton AE, Maskell N, Rahman N.

BMJ Open Respir Res. 2018 Aug 3;5(1):e000307. doi: 10.1136/bmjresp-2018-000307. eCollection 2018.

13.

An Inconvenient Truth Concerning Surgery for Mesothelioma.

de Fonseka D, Slade M, Blyth KG, Edwards J, Evison M, Roberts M, Rahman N, Woolhouse I, Maskell NA.

J Clin Oncol. 2018 Sep 10;36(26):2745-2746. doi: 10.1200/JCO.2018.78.6590. Epub 2018 Jun 14. No abstract available.

PMID:
29902107
14.

Regulation: What is there not to like?

Evison MP.

Sci Justice. 2018 Jul;58(4):300-301. doi: 10.1016/j.scijus.2018.05.006. Epub 2018 May 9. No abstract available.

PMID:
29895465
15.

Building the case for comprehensive hospital-based tobacco addiction services: Applying the Ottawa Model to the City of Manchester.

Evison M, Agrawal S, Conroy M, Bendel N, Sewak N, Fitzgibbon A, McWilliams L, Jerram J, Regan D, Shackley D, Preece R, Brown L, Barber P.

Lung Cancer. 2018 Jul;121:99-100. doi: 10.1016/j.lungcan.2018.04.010. Epub 2018 Apr 13. No abstract available.

PMID:
29739705
16.

Outpatient Talc Administration by Indwelling Pleural Catheter for Malignant Effusion.

Bhatnagar R, Keenan EK, Morley AJ, Kahan BC, Stanton AE, Haris M, Harrison RN, Mustafa RA, Bishop LJ, Ahmed L, West A, Holme J, Evison M, Munavvar M, Sivasothy P, Herre J, Cooper D, Roberts M, Guhan A, Hooper C, Walters J, Saba TS, Chakrabarti B, Gunatilake S, Psallidas I, Walker SP, Bibby AC, Smith S, Stadon LJ, Zahan-Evans NJ, Lee YCG, Harvey JE, Rahman NM, Miller RF, Maskell NA.

N Engl J Med. 2018 Apr 5;378(14):1313-1322. doi: 10.1056/NEJMoa1716883.

17.

Implementing lung cancer screening: baseline results from a community-based 'Lung Health Check' pilot in deprived areas of Manchester.

Crosbie PA, Balata H, Evison M, Atack M, Bayliss-Brideaux V, Colligan D, Duerden R, Eaglesfield J, Edwards T, Elton P, Foster J, Greaves M, Hayler G, Higgins C, Howells J, Irion K, Karunaratne D, Kelly J, King Z, Manson S, Mellor S, Miller D, Myerscough A, Newton T, O'Leary M, Pearson R, Pickford J, Sawyer R, Screaton NJ, Sharman A, Simmons M, Smith E, Taylor B, Taylor S, Walsham A, Watts A, Whittaker J, Yarnell L, Threlfall A, Barber PV, Tonge J, Booton R.

Thorax. 2019 Apr;74(4):405-409. doi: 10.1136/thoraxjnl-2017-211377. Epub 2018 Feb 13.

PMID:
29440588
18.

Prevalence of nodal metastases in lymph node stations 8 & 9 in a large UK lung cancer surgical centre without routine pre-operative EUS nodal staging.

Evison M, Edwards T, Balata H, Tempowski A, Teng B, Bishop P, Fontaine E, Krysiak P, Rammohan K, Shah R, Crosbie P, Booton R.

Lung Cancer. 2018 Jan;115:127-130. doi: 10.1016/j.lungcan.2017.11.023. Epub 2017 Nov 23.

PMID:
29290254
19.

Validation of a standard forensic anthropology examination protocol by measurement of applicability and reliability on exhumed and archive samples of known biological attribution.

Francisco RA, Evison MP, Costa Junior MLD, Silveira TCP, Secchieri JM, Guimarães MA.

Forensic Sci Int. 2017 Oct;279:241-250. doi: 10.1016/j.forsciint.2017.08.015. Epub 2017 Sep 7.

PMID:
28926780
20.

Randomized Controlled Trial of Urokinase versus Placebo for Nondraining Malignant Pleural Effusion.

Mishra EK, Clive AO, Wills GH, Davies HE, Stanton AE, Al-Aloul M, Hart-Thomas A, Pepperell J, Evison M, Saba T, Harrison RN, Guhan A, Callister ME, Sathyamurthy R, Rehal S, Corcoran JP, Hallifax R, Psallidas I, Russell N, Shaw R, Dobson M, Wrightson JM, West A, Lee YCG, Nunn AJ, Miller RF, Maskell NA, Rahman NM.

Am J Respir Crit Care Med. 2018 Feb 15;197(4):502-508. doi: 10.1164/rccm.201704-0809OC. Erratum in: Am J Respir Crit Care Med. 2018 Apr 15;197(8):1092-1093.

PMID:
28926296
21.

Adequacy of Intraoperative Nodal Staging during Surgical Resection of NSCLC: Influencing Factors and Its Relationship to Survival.

Edwards T, Balata H, Elshafi M, Foden P, Bishop P, Fontaine E, Jones M, Krysiak P, Rammohan K, Shah R, Crosbie P, Booton R, Evison M.

J Thorac Oncol. 2017 Dec;12(12):1845-1850. doi: 10.1016/j.jtho.2017.07.027. Epub 2017 Aug 4.

22.

A new approach for the analysis of facial growth and age estimation: Iris ratio.

Machado CEP, Flores MRP, Lima LNC, Tinoco RLR, Franco A, Bezerra ACB, Evison MP, Guimarães MA.

PLoS One. 2017 Jul 7;12(7):e0180330. doi: 10.1371/journal.pone.0180330. eCollection 2017.

23.

Resectable Clinical N2 Non-Small Cell Lung Cancer; What Is the Optimal Treatment Strategy? An Update by the British Thoracic Society Lung Cancer Specialist Advisory Group.

Evison M, Clive A, Castle L, Powell H, Thomas R, Buttery R, Masani V, Harden S, West D, Woolhouse I.

J Thorac Oncol. 2017 Sep;12(9):1434-1441. doi: 10.1016/j.jtho.2017.05.023. Epub 2017 Jun 15. Erratum in: J Thorac Oncol. 2019 Feb;14(2):314.

24.

Critical issues in the historical and contemporary development of forensic anthropology in Australia: An international comparison.

Mallett X, Evison MP.

Forensic Sci Int. 2017 Jun;275:314.e1-314.e8. doi: 10.1016/j.forsciint.2017.03.019. Epub 2017 Mar 31.

PMID:
28449842
25.

Research letter: Evaluating the future pathological N descriptors for lung cancer staging in a UK population.

Edwards T, Balata H, Foden P, Crosbie P, Booton R, Evison M.

Lung Cancer. 2017 Jul;109:149-151. doi: 10.1016/j.lungcan.2017.04.008. Epub 2017 Apr 15. No abstract available.

PMID:
28442146
26.

Comparison between endobronchial ultrasound-guided transbronchial biopsy and CT-guided transthoracic lung biopsy for the diagnosis of peripheral lung cancer: a systematic review and meta-analysis.

Zhan P, Zhu QQ, Miu YY, Liu YF, Wang XX, Zhou ZJ, Jin JJ, Li Q, Sasada S, Izumo T, Tu CY, Cheng WC, Evison M, Lv TF, Song Y; written on behalf of the AME Lung Cancer Collaborative Group.

Transl Lung Cancer Res. 2017 Feb;6(1):23-34. doi: 10.21037/tlcr.2017.01.01.

27.

Tissue Microarray Analysis Applied to Bone Diagenesis.

Mello RB, Silva MR, Alves MT, Evison MP, Guimarães MA, Francisco RA, Astolphi RD, Iwamura ES.

Sci Rep. 2017 Jan 4;7:39987. doi: 10.1038/srep39987.

28.

How should performance in EBUS mediastinal staging in lung cancer be measured?

Evison M, Crosbie P, Navani N, Callister M, Rintoul RC, Baldwin D, Booton R.

Br J Cancer. 2016 Oct 11;115(8):e9. doi: 10.1038/bjc.2016.253. Epub 2016 Aug 23. No abstract available.

29.

Extracorporeal Membrane Oxygenation Assisted Segmentectomy for Metachronous Lung Cancer After Pneumonectomy.

Heward E, Hayes T, Evison M, Booton R, Barnard J, Shah R.

Ann Thorac Surg. 2016 Sep;102(3):e187-e189. doi: 10.1016/j.athoracsur.2016.01.066.

PMID:
27549537
30.

EBUS-guided mediastinal lung cancer staging: monitoring of quality standards improves performance.

Evison M, Crosbie P, Martin J, Shah R, Doran H, Borrill Z, Hoyle J, Rana D, Bailey S, Booton R.

Thorax. 2016 Aug;71(8):762-3. doi: 10.1136/thoraxjnl-2015-206985. Epub 2016 May 4.

PMID:
27146201
31.

Pulmonary artery sarcoma: a rare thoracic tumor frequently misdiagnosed at presentation.

Evison M, Crosbie P, Chaturvedi A, Shah R, Booton R.

Thorac Cancer. 2015 Nov;6(6):797-9. doi: 10.1111/1759-7714.12213. Epub 2014 Dec 29.

32.

Olanzapine-induced eosinophilic pleuritis.

Evison M, Holme J, Alaloul M, Doran H, Bishop P, Booton R, Chaudhry N.

Respir Med Case Rep. 2014 Dec 16;14:24-6. doi: 10.1016/j.rmcr.2014.11.007. eCollection 2015.

34.

Reply to: "Lymph Node/Tumor SUVmax Ratio Can Predict Metastasis to Mediastinal Lymph Nodes in Lung Cancer Patients".

Evison M, Crosbie P, Booton R.

J Thorac Oncol. 2015 May;10(5):e32-3. doi: 10.1097/JTO.0000000000000511. No abstract available.

35.

Should all lung cancer patients requiring mediastinal staging with EBUS undergo PET-CT first?

Evison M, Crosbie P, Booton R.

J Bronchology Interv Pulmonol. 2015 Apr;22(2):e5-7. doi: 10.1097/LBR.0000000000000163. No abstract available.

PMID:
25887026
36.

Endobronchial ultrasound images: bronchial artery and pulmonary emboli.

Evison M, Crosbie PA, Booton R, Barber P.

J Bronchology Interv Pulmonol. 2015 Apr;22(2):142-4. doi: 10.1097/LBR.0000000000000141. No abstract available.

PMID:
25887011
37.

Can EBUS-TBNA provide an accurate diagnosis in patients found to have enlarged or FDG-avid lymph nodes during surveillance of previously treated lung cancer? A retrospective study.

Evison M, Crosbie PA, Califano R, Summers Y, Martin J, Barber PV, Booton R.

J Bronchology Interv Pulmonol. 2015 Apr;22(2):114-20. doi: 10.1097/LBR.0000000000000154.

PMID:
25887006
38.

Achieving a tissue diagnosis in PS3 patients with advanced lung cancer: what are the safety and diagnostic outcomes with EBUS?

Al-Najjar H, Evison M, Crosbie PA, Martin J, Barber PV, Booton R.

Lung Cancer. 2015 May;88(2):236-7. doi: 10.1016/j.lungcan.2015.03.001. Epub 2015 Mar 9. No abstract available.

PMID:
25783565
39.

Referral patterns for mediastinal staging with EBUS across a UK Lung Cancer Network: A report from the Manchester Cancer EBUS sub-group.

Evison M, Crosbie P, Morris J, Martin J, Shah R, Doran H, Hoyle J, Bailey S, Rana D, Sundar R, Booton R.

Lung Cancer. 2015 Apr;88(1):114-5. doi: 10.1016/j.lungcan.2015.02.001. Epub 2015 Feb 9. No abstract available.

PMID:
25703892
40.

Thoracic metastasis from renal cell carcinoma: bronchoscopic and EBUS images.

Evison M, Crosbie PA, Booton R.

J Bronchology Interv Pulmonol. 2015 Jan;22(1):55-7. doi: 10.1097/LBR.0000000000000124. No abstract available.

PMID:
25590485
41.

Diffuse pleural thickening following heart failure-related pleural effusions in an asbestos exposed patient.

Evison M, Barber P.

Int J Occup Environ Health. 2015;21(2):169-71. doi: 10.1179/2049396714Y.0000000104. Epub 2015 Jan 13.

42.

A study of patients with isolated mediastinal and hilar lymphadenopathy undergoing EBUS-TBNA.

Evison M, Crosbie PA, Morris J, Martin J, Barber PV, Booton R.

BMJ Open Respir Res. 2014 May 31;1(1):e000040. doi: 10.1136/bmjresp-2014-000040. eCollection 2014. Erratum in: BMJ Open Respir Res. 2014;1(1):e000040corr1.

43.

Nodal staging in lung cancer: a risk stratification model for lymph nodes classified as negative by EBUS-TBNA.

Evison M, Morris J, Martin J, Shah R, Barber PV, Booton R, Crosbie PA.

J Thorac Oncol. 2015 Jan;10(1):126-33. doi: 10.1097/JTO.0000000000000348.

44.

Can computed tomography characteristics predict outcomes in patients undergoing radial endobronchial ultrasound-guided biopsy of peripheral lung lesions?

Evison M, Crosbie PA, Morris J, Martin J, Barber PV, Booton R.

J Thorac Oncol. 2014 Sep;9(9):1393-7. doi: 10.1097/JTO.0000000000000249.

45.

Stage distribution and performance status of newly diagnosed patients in a UK regional mesothelioma centre.

Khan S, Evison M, Alaloul M, Holme J, Booton R, Taylor P.

Lung Cancer. 2014 Jul;85(1):99-100. doi: 10.1016/j.lungcan.2014.03.024. Epub 2014 Apr 4. No abstract available.

PMID:
24780110
46.

EBUS-TBNA in elderly patients with lung cancer: safety and performance outcomes.

Evison M, Crosbie PA, Martin J, Bishop P, Doran H, Joseph L, Chaturvedi A, Barber PV, Booton R.

J Thorac Oncol. 2014 Mar;9(3):370-6. doi: 10.1097/JTO.0000000000000085.

47.

Cerebral air embolism following transbronchial lung biopsy during flexible bronchoscopy.

Evison M, Crosbie PA, Bright-Thomas R, Alaloul M, Booton R.

Respir Med Case Rep. 2014 Mar 28;12:39-40. doi: 10.1016/j.rmcr.2013.10.005. eCollection 2014.

48.

Sarcomatoid mesothelioma with osteoid differentiation.

Evison M, Crosbie PA, Howe M, Booton R.

J Thorac Oncol. 2013 Sep;8(9):1222-3. doi: 10.1097/JTO.0b013e31829f6b2c. No abstract available.

49.

Forensic facial comparison: issues of admissibility in the development of novel analytical technique.

Mallett X, Evison MP.

J Forensic Sci. 2013 Jul;58(4):859-65. doi: 10.1111/1556-4029.12127. Epub 2013 May 29.

PMID:
23718761
50.

Novel one-stop multidisciplinary follow-up clinic for BRCA1/2 carriers: patient satisfaction and decision making.

Firth C, Jacobs C, Evison M, Pichert G, Izatt L, Hunter MS.

Psychooncology. 2011 Dec;20(12):1301-8. doi: 10.1002/pon.1846. Epub 2010 Oct 3.

PMID:
22114045

Supplemental Content

Loading ...
Support Center